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RESUMO 
Obiedivo: rever o perfil cllnico dos doentes com 
Pneumonia por Staphylococcus aureus no Servi~o de 
Pneumologia do Centro Hospitalar Conde S. Janua-
rio. 
Desenho: analise retrospectiva. 
Metodos: foram revistos os processos clinicos e 
radiologicos bem como os resultados bacteriologicos 
e a resposta a terapeutica de todos OS doentes inter-
nados, num Servi~o de Pneumologia, com o diagnos-
tico de pneumonia por estafilococos, durante o 
pertodo compreendido entre 1991 e 1994. 
ABSTRACT 
Obiective : To review the clinical profile of 
patients with Pneumonia due to Staphylococcus 
aureus at the Pneumology Service of Centro Rospi-
talar Conde S. Januario. 
Design: A retrospective analysis. 
Methods: The case notes, the chest radiographs, 
the microbiology results and the response to therapy 
of patients with staphylococcus pneumonia, admitted 
at the hospital for a period 1991-L994, were reviewed. 
Results: A total of 10 males patients, with mean 
age 27,9 year (range 16 to 34 years) were notified as 
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Resultados: um total de 10 doentes, todos do sexo 
mascullno, com uma media de idades de 27,9 anos 
(16-34), como diagn6stico de pneumonia estafiloc6-
cica foram analisados. Todos eles (100%) eram 
toxicomanos por via parenterica. Tosse, dispneia, 
febre, astenia e anorexia foram as manifesta~6es 
clinicas predominantes. lnfiltrados bilaterais multi-
plos e pneumatocelos, na radiografia de torax, 
ocorreram em todos os doentes. Tres doentes tive-
ram como complica~o endocardite, tres com pneu-
mot6rax, dois com derrame pleural, dois com insufi-
ciencia renal aguda e um com insuficiencia hepatica. 
0 Staphylococcus aureus foi isolado em hemocultu-
ras de todos (10/10) os doeotes e em expectora~ao de 
apenas dois (2/4). Todas as estirpes eram sensfveis 
aos derivados semi-sinteticos da penicilina. Todos os 
doentes registaram desaparecimento da sintomatolo-
gia e melhoria radiol6gica ap6s antibioterapia. 
Conclus6es: os toxic6manos que utilizem a via 
parenterica constituem um grupo de risco para 
bacteriemia estafilocociu, infec~ao da valvula 
tricuspid& e pneumonia bilateral. 
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INTRODUCTION 
Community acquired pneumonia is a serious 
illness, associated with significant morbidity and 
mortality ( 1) and have a significant impact on the 
health care system. Staphylococcal pneumonia is 
fairly uncommon but very serious (2) and associated 
with a hlgh mortality (30-40%) even with appropriate 
therapy (3,4,5). Therefore, the preantibotic era's morta-
lity rates of more than 90% decrease dramatically (6). 
The Staphylococcus aureus is the second most 
common infectious agent of pneumonia in the ICU (7). 
This organism produces a large array of enzymes and 
toxins that contribute to the remarkable pathogenicity 
CS) that result in severe damage to lung tissue. Staph-
ylococcus aureus infects the lungs by the aerogenous 
or hematogenous route. The aerogenous route is the 
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having staphylococcus pneumonia between 1991 and 
1994. All of them (100%) were intravenous drug 
addicts. Cough, dyspnea, fever, fatigue and anorexia 
were the predominant clinical manifestations. 
Multiple bilateral infiltrates and pneumatoceles on 
the chest radiograph occurred on all of the patients. 
3 patients were complicated with endocarditis, 3 
with pneumothorax, 2 with pleural effusion, 2 with 
acute renal failure and one with liver failure. The 
staphylococcus OlUeUS was isolated from the blood 
culture in all patients (10/10) and 2 (2/4) from the 
sputum cultures. All strains were semisyntetic 
penicillins sensible. All the patients had complete 
resolution of the symptoms and improvement in the 
chest radiograph fandings after antibiotic therapy. 
Conclusions: Drug addicts who use parenteral 
routes are especially prone to Staphylococcal bacte-
remia, tricuspid valve infection, and bilateral pneu-
monia. 
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classic one and is similar to the way in which most 
other types of pneumonia . There is an increased 
incidence of Staphylococcus aureus pneumonia in 
patients who suffered a recent bout of influenza (7), 
and in older patients (than 50years) with one or more 
underlying diseases. 
However, hematogeneous pulmonary infection is 
not uncommon and is often severe especially in 
hospitalized patients (6). 
The skin is the major site of entry ofhematogene-
ous spread of Staphylococcus aureus to the lungs 
through bacteremia, whlch ensues as a result of one of 
a variety of disease processes. It was reported to occur 
in association with skin and soft tissue infection(9), 
bums ( 1 0 ), pyomyositis, infected intravenous catheter, 
valves prostheses, dialysis shunts, and in drug addicts 
who use parenteral routes (9,11.12,13). These are 
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especially prone to staphylococcal bacteremia, renal, 
splenic or bone abscesses, endocardites, and pneumo-
nia (14,15). 
Perhaps relevant is the observation that drug 
addicts have higher staphylococcal carrier rates for 
nose and sldn than does the population at large. 
Often, the diagnosis is clear: shaking chills, remit-
tent (or intermittent) fever in a patient with a skin 
wound or evident source of stapby lococci followed by 
symptoms referable to the respiratory tract and pulmo-
nary infiltrates. Cough, purulent sputum, and chest 
pain are common. Hemoptysis may occur, "dirty 
salmon pink" sputum is not typical for this disease. 
The classical radiographic findings are that of bilateral 
bronchopneumonia and necrosis, leading to early 
excavation and the formation of thin-walled lung 
abscesses. The complications ofintrathoracic infection 
are exceedingly diverse because of the widespread 
foci: focal pneumatocele formation and subpleural 
emphysema are sometimes stinking; bronchopleural 
fistula with pyopneumothorax, pleural effusion and 
empyema are common. Endocardites with tricuspid 
valve evolvement without a history of prior heart 
disease is a well-recognized complication of staphylo-
coccal bematogeneous infection of drug addicts (14). 
In this patients a history of prior heart disease is 
usually absent and the incidence of tricuspid valve 
involvement, otherwise very low, approximates 50% 
( 16). 
Multiple blood cultures drawn before the initiation 
of therapy are extremely important in patients with 
suspected staphylococcal bacteremia. 
Between 1991-1994 we review the patients that 
was admitted in the ward of Pneumology Department, 
with the diagnosi~ of Staphylococcal Pneumonia. 
MATERIAL AND METHODS 
All registered admissions in the Pneumology 
Service of Centro Hospitalar de Conde S. Januario, 
since January 1991 to December 1994, were retros-
pectively reviewed in detai l with the clinical charts. 
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Patients with staphylococcal pneumonia were identifi-
ed. Data were collected on age, sex, interval (days) 
between the onset of symptoms and the admission in 
the hospital, smoldng and alcoholics habits (daily 
alcohol ingestion > 80g), intravenous drug addiction, 
underlying diseases, laboratory findings, radiologic 
features, complications, microbiologic specimens and 
therapeutic outcome. 
RESULTS 
Patient population 
From I January 199 1 to 31 December 1994 a total 
of 174 7 patients were admitted in the Pneumology 
Service of Centro Hospitalar de Conde S. Januano. Of 
the 48 (2,7%) patients with hospital discharge diagilO-
sis of community-acq uired pneumonia, I 0 ;Jatients 
suffered of Staphylococcal pneumonia. The I 0 pati· 
ents, that consisted the study population, were men, 
with a mean age of27.9 years (range 16 to 34 years). 
The racial distribution included one Caucasian and 9 
Chinese patients. 
All of patients were intravenous drug addicts with 
an average duration of drug abusing of9 years (range 
8 months to 14 years). Four referred smoking habits 
and all ten patients had no underlying diseases or 
alcohol abuse. 
Duration ofhospital stays range from 19 to 39 days 
with a mean stay of29.5 days. 
Clinical presentation 
The median duration of respiratory and constitutio-
nal symptoms before the admission was 8.3 days 
(range 5 to 20 days). The onset of illness was typically 
acute with defming initial event. The most common 
initial respiratory symptom was cough, which was 
present in all patients; cough was productive in 9 of 
patients and bloody sputum appeared in 4 patients. 
The second most common respiratory symptom was 
dyspneia that occurred in 8 patients. Chest pain was 
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present in only one patient. High-grade fever, anorexia 
and generalized weakness were the prevalent constitu-
tional symptoms that were reported in all ten patients. 
Weight loss occurred in two patients (Table 1 ). 
TABLE I 
Symptoms of presentation in I 0 drug addicts patients with 
Staphylococcus au reus pneumonia 
Symptoms N" of Pts 
Respiratory 
cough 10 
productive 9 
dispnea 8 
hemoptysis 5 
chest pain I 
Constitutional 
fever 10 
anorexia 10 
fatigue 10 
weigth loss 2 
Laboratory findings 
Nine patients were anemic (Hct < 40 percent) and 
the majority was classified normochromic and nom1i-
citic. The ESR ranged from 62 to I 15 mm/h. Throm-
bocytopenia (<I OO.OOO/mm3) was observed in three 
patients. Ten patients had leucocytosis with a mean of 
15.860 /mm3 of peripheral white blood cell count. 
Creatinine concentration was increased(> 125JJmol) 
in two patients and hyponatremia was referenced in 
seven (70%) patients. 
Hyperbilirubinemia and hypoalbuminemia 
(<30g/L) was encountered respectively in five (50%) 
and six (60%) patients. None ofthc ten patients was 
infected with H1Y. 
Five patients revealed hipoxaemia that range from 
59 to 73 mmHg and four of these with hypocapnea 
(PaC02<32mmHg). 
The appearance on the chest radiographic was 
similar for the I 0 patients. Diffuse patchy areas of 
infiltrates and multiple bilateral areas of cavitation 
(pneumatoceles) were seen on admission. Three (3/1 0) 
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patients had associated pneumothorax and two (21 I 0) 
pleural effusions, that no tum out to be empyema. 
In five patients with murmur examined by echocar-
diography three had demonstrable vegetation on the 
tricuspid valve. 
All of the ten ( I 00%) patients had positive blood 
cultures for Staphylococcus aureus. The sputum 
culture was positive in three patients and one of them 
yield more than one pathogen; in one patient the 
Staphylococcus aureus growth on the urine culture. 
All the Staphylococcus aureus isolates were penicillin 
resistant. 
Treatment 
All patients received empmc initial antibiotic 
therapy, tacked into account the clinical and epidemio-
logical history, and the chest radiograph findings with 
previous collect of samples for blood, sputum and 
urine culture. 
One the initial, five patients received a 
penicillinase-resistant penicillin, three patients was 
treated with vancomycine, one with a third-generation 
cephalosporin and another with erytromicine. Combi-
nation therapy was used in six patients: in 5 patients 
added with an aminoglycoside and one with a third-
generation cephalosporinc. 
Changing of antibiotic therapy occurred in 3 
patients: one patient that had made erythromycin 
during two days changed to, a penicilinase-resistant 
penicillin after staphylococcus aureus was recovered 
from blood culture; one patient that had received a 
third-generation cephalosporin and another treated 
with a penicilinase-resistant penicillin were changed 
to vancomycine because revealed allergic to penicil-
lins derivate. The three patients that had vegetations 
on the tricuspid valve detected by echocardiography 
was treated with a penicilinase-resistant penicillin or 
vancomycine associated with aminiglycoside. 
The length of treatment was between 3 and 6 weeks. 
In all patients the medical treatment was s_uccessful 
with a complete clinical resolution and improvement 
of the chest radiographs findings. 
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Fig. I - Chest radiograph from 22 year-old man drug add1ct w1th 
staphylococcal pneumonia (pneumatoceles) 
DISCUSSIO N 
The epidemiology of staphylococcal pneumonia 
was first scrutinized during the preantibiotic era by 
Chikering and Park in 1919 ( 17). They reported 155 
patients who developed Staphylococcus aureus pneu-
monia after an influenza outbreak. During 1950, authors 
focused on differences between adult and pediatric 
patients with staphylococcal pneumonia (18). Staphylo-
coccus was responsible for 15% of primary pneumonia, 
which was a notable increase from prior reports (19). 
Recent adult community-acquired cases have followed 
influenza in 52% of cases (20). A substantial percentage 
of these patients were tobacco and alcohol users, and 
half preexisting chronic diseases. 
Recent articles support the distinction between 
aerogenous and hematogenous staphylococcal pneu-
monia (9,21 ). In Jess developed areas of the world, the 
hematogeneous variety continues to be seen in the 
setting of skin and soft tissues infections (22). In the 
United States, the source of bacteremia is more typi-
cally from tricuspid valve endocardites related to 
intravenous drug abuse, intravascular catheters, or 
hemodialysis (9). 
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Data collected from our retrospective study of 48 
patients admitted to the Pneumology Service of 
CHCSJ for community-acquired pneumonia, between 
1991 and 1994, ten (20.8%) fulfilled the criteria for 
staphylococcal pneumonia. All of I 0 patients were 
young men and intravenous drug addicts. 
Intravenous drug abusers arc an important risk 
group for acquiring HIV. None of our patients was 
infected with HJV or had underlying disease. 
The illness, before diagnosis, had a mean duration 
of8.3 days that was similar than the review of Cham-
bers et at (23). 
When first seen our ten patients, the criteria of 
sepsis and bacteremia (24) were fulfilled respectively 
by seven (70%) and three (30%) patients. 
Bilateral septic pulmonary embolus was observed 
in all I 0 ( I 00%) patients, suggested by the chest 
radiograph findings that showed multiple and bilateral 
infiltrates and cavitation (pneumatoceles). 
Staphylococcal endocardites is a condition affec-
ting intravenous drug abusers at increasing rates ( 15). 
Staphylococcus au reus may attack normal or damaged 
native valves, or prosthetic valves, and has predilecti-
on for the tricuspid valve in drug addicts (25). Julander 
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et al (26) consider that the triad drug addiction-staph-
ylococcal septicemiapulmonary embolism is pathog-
nomonic for tricuspid valve endocardites. Conse-
quently, patients fulfilling these criteria should be 
treated as suffering from endocardites, although no 
significant murmur can be heard or the echocardio-
graphy had no consistent with tricuspid valve endocar-
ditis. 
In our study, five patients with staphylococcal 
pneumonia and murmur cxan1ined by echocardio-
graph, only three had vegetation on the normal native 
tricuspid valve. Staphylococcus aureus bacteremia 
may be a cause or a result of pneumonia (9,27) and the 
blood culture in the appropriate clinical setting provide 
the cause of pneumonia (7). All of the ten (I 00%) 
patients we studied had positive blood culture for 
Staphylococcus au reus. 
Treatment of staphylococcal infection requires 
selection of optimal therapy based on susceptibility 
testing, antimicrobial pharmacokinetics, and conside-
ration of therapeutic index of the selected antimicrobi-
al drugs (7). The semisynthetic penicillins are the most 
active agents against strains of penicillinase produc-
ring that compose more than 90% of strains of staph-
ylococcus aureus iso lated. The majority of 
community-acquired staphylococci arc penicillin 
resistant (3). There tore, initial therapy is semisynthetic 
penicillin. 
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